L. Silver
Molecular Biology · 2006–2017
A researcher in the Science corpus: 3 papers; trusts 4 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 16 citations into it
- Molecular Medicine — 12 citations into it; #112 of 296 by trust here, #112 by citations
- Pharmacology — 7 citations into it
- Genetics — 5 citations into it
Whom L. Silver trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts L. Silver overall
Papers from L. Silver's perspective
Ordered by how strongly the researchers L. Silver trusts endorse each paper. Same corpus, a different order for every researcher.
- Multidrug-resistance efflux pumps ? not just for resistance (Nature Reviews Microbiology)
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis (Science)
- Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase (Nature Medicine)
- Lessons from natural molecules (Nature)
- Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria (Nature)
- Sampling the Antibiotic Resistome (Science)
- Efflux-mediated antimicrobial resistance. (Journal of Antimicrobial Chemotherapy)
- Structure and function of bacterial outer membrane proteins: barrels in a nutshell (Molecular Microbiology)
- Glycopeptide and lipoglycopeptide antibiotics. (Chemical Reviews)
- Biosynthesis of Complex Polyketides in a Metabolically Engineered Strain of E. coli (Science)
Their papers
- Platensimycin is a selective FabF inhibitor with potent antibiotic properties (2006) — 737 citations
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) — 4,785 citations
- Challenges of Antibacterial Discovery (2011) — 1,193 citations